Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Chronic Renal Failure

Free Subscription 20.04.2026 3 Am J Kidney Dis 2 Am J Nephrol 2 Clin J Am Soc Nephrol 2 Clin Nephrol 1 J Am Soc Nephrol 1 J Clin Endocrinol Metab 1 J Nephrol 1 J Ren Nutr 1 Nephrol Dial Transplant 3 Pediatr Nephrol 2 PLoS One 5 Ren Fail 2 Semin Dial

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Kidney Dis

1. LU Y, Li J, Cui Y
   Apixaban Initiation in Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
   Am J Kidney Dis. 2026 Apr 10:S0272-6386(26)00839.
   PubMed        
   
   
2. WINKELMAYER WC, Chang TI
   In Reply to: "Unmasking the Survival Benefit: Vascular Fragility and Selection Bias in Dialysis Anticoagulation" and "Apixaban Initiation in Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation".
   Am J Kidney Dis. 2026 Apr 10:S0272-6386(26)00840.
   PubMed        
   
   
3. WANG B, Huang J, Chen Z
   Unmasking the Survival Benefit: Vascular Fragility and Selection Bias in Dialysis Anticoagulation.
   Am J Kidney Dis. 2026 Apr 10:S0272-6386(26)00838.
   PubMed        
   
   

   
   Am J Nephrol

4. ELENJICKAL EJ, Mavrakanas TA
   Mineralocorticoid Receptor Antagonists in Dialysis.
   Am J Nephrol. 2026 Apr 15:1-27. doi: 10.1159/000551881.
   PubMed         Abstract available
   
   
5. MERZKANI M, Attieh RM, Jhaveri KD, Murakami N, et al
   Immunotherapy and cellular therapies for cancers in kidney transplant patients.
   Am J Nephrol. 2025 Feb 20:1-23. doi: 10.1159/000544826.
   PubMed         Abstract available
   
   

   
   Clin J Am Soc Nephrol

6. NANCHEN G, Marasa M, Breno M, Martinatto C, et al
   Natural History and Clinical Associations with Long-Term Outcomes in Primary C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GN.
   Clin J Am Soc Nephrol. 2026;21:626-640.
   PubMed         Abstract available
   
   
7. CHAN RJ, Arustei D, D'Gama C, Faratro R, et al
   Optimizing Home Hemodialysis Vascular Access Infection Outcomes Through Continuous Quality Improvement.
   Clin J Am Soc Nephrol. 2026 Apr 10. doi: 10.2215/CJN.0000001056.
   PubMed        
   
   

   
   Clin Nephrol

8. JIANG Q, Yu J, Zhao Y, Xiao Y, et al
   Simplified nutritional and inflammatory indicators for long-term survival from all-cause mortality in maintenance hemodialysis.
   Clin Nephrol. 2026 Apr 17. doi: 10.5414/CN111855.
   PubMed         Abstract available
   
   
9. SUBHASH S, Rabbani H, Dhillon N, Glass N, et al
   From shelter to stroke: A mediation-proxy analysis of homelessness-associated stroke risk in dialysis patients.
   Clin Nephrol. 2026 Apr 17. doi: 10.5414/CN111835.
   PubMed         Abstract available
   
   

   
   J Am Soc Nephrol

10. DAVIS JW, Layton JB, Sahrmann JM, Nickel KB, et al
    Comparative Effectiveness of Different Influenza Vaccine Formulations among Patients Undergoing Maintenance Hemodialysis.
    J Am Soc Nephrol. 2026 Apr 13. doi: 10.1681/ASN.0000001099.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

11. MOHSEN M, Yi TW, Faruque L, Ke C, et al
    Combination Treatment for Management of Chronic Kidney Disease and Type 2 Diabetes: A Review and Practical Guidance.
    J Clin Endocrinol Metab. 2026 Apr 13:dgag163. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Nephrol

12. SANTOS AS, Dufour I, Morelle J, Goffin E, et al
    An integrated home dialysis model facilitates transition from peritoneal dialysis to self-care hemodialysis: evidence from a Belgian cohort.
    J Nephrol. 2026 Apr 17:aajag004. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Ren Nutr

13. WITTENDORFF PEDERSEN AE, Rousing AQ, Berg P, Christensen JF, et al
    Effects of a Low-PRAL Modified New Nordic Renal Diet on Acid-Base Status in Patients With Stage 4-5 Chronic Kidney Disease and Chronic Metabolic Acidosis.
    J Ren Nutr. 2026 Apr 15:S1051-2276(26)00081-6. doi: 10.1053/j.jrn.2026.
    PubMed         Abstract available
    
    

    
    Nephrol Dial Transplant

14. IDOWU A, Lo KB, Mathew R, Navaneethan SD, et al
    Cardiovascular Outcomes and Acute Kidney Injury Risk with Combination Therapies in Type 2 Diabetes and Chronic Kidney Disease.
    Nephrol Dial Transplant. 2026 Apr 15:gfag087. doi: 10.1093.
    PubMed        
    
    

    
    Pediatr Nephrol

15. GUTIERREZ E, Sevillano AM, Caravaca-Fontan F, Trujillo H, et al
    Chronic kidney disease progression in glomerular diseases: is hematuria a key risk factor?
    Pediatr Nephrol. 2026 Apr 13. doi: 10.1007/s00467-026-07201.
    PubMed         Abstract available
    
    
16. AKAY N, Aksu B, Yildirim ZY, Kardelen Al AD, et al
    Baseline height Z-score as an early marker of chronic kidney disease progression: insights from a two-year follow-up.
    Pediatr Nephrol. 2026 Apr 14. doi: 10.1007/s00467-026-07282.
    PubMed         Abstract available
    
    
17. CHO MH, Yang EM
    Response to Letter to the Editors "Factors influencing serum uric acid levels and their impact on cardiovascular risk in pediatric chronic kidney disease".
    Pediatr Nephrol. 2026 Apr 15. doi: 10.1007/s00467-026-07255.
    PubMed        
    
    

    
    PLoS One

18. DIAS GF, Fan C, Han M, Wang X, et al
    COVID-19 in hemodialysis patients: New insights into metabolomic profile dynamics from 60 days pre- to 60 days post-diagnosis.
    PLoS One. 2026;21:e0346687.
    PubMed         Abstract available
    
    
19. URENA TORRES PA, Naja M, Tran MH, Cohen-Solal M, et al
    Effect of dialysate buffer practices on serum parathyroid hormone concentrations in real-life french patients receiving hemodialysis.
    PLoS One. 2026;21:e0345776.
    PubMed         Abstract available
    
    

    
    Ren Fail

20. MUTIS ALAN A, Yalin SF, Atas I, Alan O, et al
    Acute hemodialysis for cancer-associated acute kidney injury: etiologies, indications, and outcomes from a 25-year single-center experience.
    Ren Fail. 2026;48:2651473.
    PubMed         Abstract available
    
    
21. CHEN XY, Fan YL, Hao J
    Value of different nutritional and inflammatory markers for diagnosis of peritonitis in patients undergoing peritoneal dialysis.
    Ren Fail. 2026;48:2650574.
    PubMed         Abstract available
    
    
22. ZHAO A, Chen B, Lin C, Wang W, et al
    Molecular mechanism of Yishen Qingzhuo oral liquid in treating chronic renal failure via the Nrf2/HO-1-mediated ferroptosis pathway.
    Ren Fail. 2026;48:2653928.
    PubMed         Abstract available
    
    
23. ZHU B, Zou X, Chen Y, Lu Y, et al
    A comparative study on demographics and blood biomarkers associated with chronic kidney disease in hypertensive and non-hypertensive individuals.
    Ren Fail. 2026;48:2653937.
    PubMed         Abstract available
    
    
24. CHEN Y, Ren S, Yao X, Li M, et al
    Benefits of physical exercises in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.
    Ren Fail. 2026;48:2654288.
    PubMed         Abstract available
    
    

    
    Semin Dial

25. SIVARAM P, Johnson T, Mortazavi M, Anandh U, et al
    Green Dialysis: A Framework for Environmentally Sustainable Renal Replacement Therapy.
    Semin Dial. 2026 Apr 14. doi: 10.1111/sdi.70028.
    PubMed         Abstract available
    
    
26. FATIMA SB, Khan MA, Zafar S
    Beyond Bioremediation: A Rare Case of Comamonas testosteroni Bloodstream Infection in a Patient With Stage 5 Chronic Kidney Disease on Maintenance Hemodialysis.
    Semin Dial. 2026 Apr 13. doi: 10.1111/sdi.70026.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum